Supplement Industry "Dramatically Undervalued" By Investors - Analyst
This article was originally published in The Tan Sheet
Executive Summary
Nutritional supplement companies will provide "significant investment opportunities over the next decade," Adams, Harkness & Hill Managing Director of Research Matthew Patsky said at the Council for Responsible Nutrition annual conference in Palm Springs, Calif. Oct. 4-6.
You may also be interested in...
W-L Quanterra Supplements Nine-Month Sales Reach $9.1 Mil.
Warner-Lambert's Quanterra line of dietary supplements posted sales of $2.8 mil. and $9.1 mil. for the three and nine months ended Sept. 30, respectively. The brand began appearing on shelves just over a year ago.
W-L Quanterra Supplements Nine-Month Sales Reach $9.1 Mil.
Warner-Lambert's Quanterra line of dietary supplements posted sales of $2.8 mil. and $9.1 mil. for the three and nine months ended Sept. 30, respectively. The brand began appearing on shelves just over a year ago.
W-L Quanterra Supplements Nine-Month Sales Reach $9.1 Mil.
Warner-Lambert's Quanterra line of dietary supplements posted sales of $2.8 mil. and $9.1 mil. for the three and nine months ended Sept. 30, respectively. The brand began appearing on shelves just over a year ago.